March 30th, 2014
Ideas Lost, But Not Stolen
Seth Shay Martin, MD
A fellow blogs about an unfortunate experience at ACC.14 – and how it it made him realize the value of his work.
March 29th, 2014
No Benefit Found in First Real Test of Renal Denervation
Larry Husten, PHD
SYMPLICITY HTN-3, the eagerly awaited first rigorous test of renal denervation, shows that the real effect of the novel blood-pressure-lowering technology is dramatically lower than earlier expectations, which had been fueled by data from previous uncontrolled trials. Results of SYMPLICITY HTN-3 were presented at the American College of Cardiology conference in Washington, DC, and published simultaneously […]
March 28th, 2014
Changing My Priorities for ACC.14
Kumar Dharmarajan, MD MBA
A fellow finds that, as his life and career changes, so does his choice of itinerary at ACC.
March 28th, 2014
ACC.14 Headquarters
wpengine
As ACC.14 unfolds, check our Headquarters page for all of our latest coverage!
March 27th, 2014
What’s Behind the Decline in Nuclear MPI Use?
Kim Williams, MD and John Ryan, MD
John Ryan asks Kim Williams for his perspective on what’s behind a sharp decline in the use of nuclear MPI since 2006.
March 25th, 2014
Glucose Measurements Don’t Improve Cardiovascular Risk Assessment
Larry Husten, PHD
Although blood glucose and glycated hemoglobin (HbA1c) play a central role in diabetes, the value of these measurements to assess cardiovascular risk has been unclear. Now, in a paper published in JAMA, members of the Emerging Risk Factors Collaboration analyze data from nearly 300,000 people without known diabetes or cardiovascular disease who were enrolled in 73 prospective studies. […]
March 25th, 2014
The Next Big Patient-Centered Initiative: Spiritual Care
Nicholas Bergfeld, BS, BA
Medical student Nick Bergfeld shares his thoughts about a need that many patients have but that medical practice largely neglects.
March 24th, 2014
Selections from Richard Lehman’s Literature Review: March 24th
Richard Lehman, BM, BCh, MRCGP
This week’s topics include non-leg venous thrombosis in critically ill adults, a comparison of factor Xa inhibitors and warfarin for preventing stroke and thromboembolism in atrial fibrillation, and more.
March 24th, 2014
ACC.14 Preview: Renal Denervation, TAVR Comparisons, and More
Larry Husten, PHD
The ACC begins this Saturday in Washington, DC. Here’s a preview of some of the most highly anticipated late-breaking clinical trials: On Saturday morning at the opening session the world will finally learn more about the failure of Symplicity HTN-3, the Medtronic trial of renal denervation. Until recently, renal denervation was thought to be an extremely […]
March 17th, 2014
Happy St. Patrick’s Day!
CardioExchange Editors, Staff
To commemorate the day, the editors and staff at CardioExchange bring you their gallery of adorable Irish children (yes, we are Boston-based). If you are Irish — or feel Irish today! — submit your own photos; we’ll happily add them! Lá Fhéile Pádraig Sona Daoibh!
NEJM Journal Watch — Recent Cardiology Articles- CTA-Guided Care in Stable Angina: Long-Term Results
- Patients Need Standardized Education for Accurate Home Blood Pressure Monitoring
- Does P2Y12 Inhibitor Pretreatment Improve Outcomes in Non–ST-Segment Elevation Acute Coronary Syndromes?
- Is Anticoagulation Useful for Patients with Subclinical Atrial Fibrillation?
- Is Anticoagulation Alone Sufficient After Caval or Iliofemoral Venous Stenting for PTS?